NCT05725200 2023-02-21
EVIDENT
Oslo University Hospital
Phase 2 Recruiting
Clinical Trials
5 trialsNCT00419159 2019-04-23
Efficacy and Safety of Everolimus in Patients With Metastatic Colorectal Cancer Who Have Failed Prior Targeted Therapy and Chemotherapy
Novartis
Phase 2 Completed
NCT00390364 2014-10-08
Everolimus in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Previous Therapy
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Terminated
NCT01387880 2012-03-20
ICE
Herlev Hospital
Phase 2 Completed
NCT00337545 2007-10-10
Phase II Trial of RAD001 in Refractory Colorectal Cancer
Swedish Medical Center
Phase 2 Completed